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abstract
 
Rod vision begins when 11-cis-retinal absorbs a photon and isomerizes to all-trans-retinal (ATR)
within the photopigment, rhodopsin. Photoactivated rhodopsin triggers an enzyme cascade that lowers the con-
centration of cGMP, thereby closing cyclic nucleotide–gated (CNG) ion channels. After isomerization, ATR disso-
ciates from rhodopsin, and after a bright light, this release is expected to produce a large surge of ATR near the
CNG channels. Using excised patches from 
 
Xenopus
 
 oocytes, we recently showed that ATR shuts down cloned rod
CNG channels, and that this inhibition occurs in the nanomolar range (aqueous concentration) at near-physio-
logical concentrations of cGMP. Here we further characterize the ATR effect and present mechanistic informa-
tion. ATR was found to decrease the apparent cGMP afﬁnity, as well as the maximum current at saturating cGMP.
When ATR was applied to outside-out patches, inhibition was much slower and less effective than when it was ap-
plied to inside-out patches, suggesting that ATR requires access to the intracellular surface of the channel or
membrane. The apparent ATR afﬁnity and maximal inhibition of heteromeric (CNGA1/CNGB1) channels was
similar to that of homomeric (CNGA1) channels. Single-channel and multichannel data suggest that channel in-
hibition by ATR is reversible. Inhibition by ATR was not voltage dependent, and the form of its dose–response re-
lation suggested multiple ATR molecules interacting per channel. Modeling of the data obtained with cAMP and
cGMP suggests that ATR acts by interfering with the allosteric opening transition of the channel and that it prefers
closed, unliganded channels. It remains to be determined whether ATR acts directly on the channel protein or in-
stead alters channel–bilayer interactions.
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INTRODUCTION
 
Cyclic nucleotide–gated (CNG) channels are members
of the voltage-gated channel family and are the subject
of many reviews (Finn et al., 1996; Pugh, 1996; Zagotta
and Siegelbaum, 1996; Karpen, 1997; Li et al., 1997;
Molday and Molday, 1998; Biel et al., 1999; Broillet and
Firestein, 1999; Frings, 1999; Richards and Gordon,
2000; Bradley et al., 2001; Flynn et al., 2001; Kaupp and
Seifert, 2002; Warren and Molday, 2002; Zimmerman,
2002; Matulef and Zagotta, 2003). CNG channels that
mediate the light response in retinal rods are nonselec-
tive cation channels that are weakly voltage dependent
and are thought to be tetramers consisting of one
 
 
 
- and three 
 
 
 
-subunits. They can be modulated by
a number of factors, including phosphorylation en-
zymes, Ca
 
2
 
 
 
/calmodulin, and divalent cations. We re-
cently found that rod CNG channels can also be modu-
lated by all-trans-retinal (ATR) and related compounds
(Dean et al., 2002).
ATR is a member of a class of compounds called ret-
inoids that includes vitamin A and its derivatives (Nau
and Blaner, 1999). Retinoids regulate a wide variety of
physiological processes, including gene transcription,
immune responses, and visual transduction. In rod vi-
sual transduction, the only direct action of light is the
photoisomerization of the retinoid chromophore 11-
cis-retinal to ATR within opsin, the protein portion of
the photopigment rhodopsin, in the rod disk mem-
brane. This isomerization induces a conformational
change in rhodopsin, which leads to the activation of a
GTP-binding protein, transducin. Transducin then acti-
vates a phosphodiesterase, which hydrolyzes cGMP to
5
 
 
 
-GMP. The resulting decrease in cGMP concentration
causes closure of CNG ion channels in the rod outer
segment plasma membrane, hyperpolarizing the cell,
and reducing the release of glutamate onto retinal bi-
polar cells (Rodieck, 1998; Pugh and Lamb, 2000; Roof
and Makino, 2000; Burns and Baylor, 2001; Fain et al.,
2001; Zimmerman, 2001).
After light activates the transduction cascade, ATR is
released from its binding pocket in rhodopsin into the
rod disk interior, where it apparently binds an ABCR
transporter that shuttles it across the disk membrane
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into the cytosol to be converted by retinol dehydroge-
nase to ATR (Sun et al., 1999; Weng et al., 1999; Ahn et
al., 2000). Next, all-trans-retinol is transferred from the
rod outer segment to the extracellular space, where it
may be complexed with interphotoreceptor retinoid
binding protein (IRBP; Pepperberg et al., 1993), which
appears to protect it from degradation. All-trans-retinol
then enters the surrounding retinal pigment epithelial
cells, where it is converted back into 11-cis-retinal,
which is eventually returned to the rod to be reinserted
into opsin (Crouch et al., 1996; Saari, 1999). Each of
these processes is occurring in the tens of minutes re-
quired to reset rhodopsin during dark adaptation after
exposure to bright light. At the same time, other com-
ponents in the transduction cascade are also being re-
set. This includes production of cGMP by guanylate cy-
clase, so that CNG channels can reopen.
Approximately 3 mM ATR is expected to be released
from rhodopsin in bright light, if the rod outer seg-
ment is considered as a single compartment (Saari,
1999). Since retinoids have been shown to modulate
several kinds of ion channels (Sidell and Schlichter,
1986; Bosma and Sidell, 1988; Fukuhara et al., 1997;
Vellani et al., 2000; Zhang and McMahon, 2000, 2001),
it seemed natural to ask whether they might also modu-
late rod CNG channels. We recently showed that ATR
can induce long shut states in rod CNG channels, and
that it acts in the nanomolar range at near physiological
cGMP concentrations (Dean et al., 2002). Here we fur-
ther characterize the inhibition of rod CNG channels by
ATR, and suggest that ATR is a closed-state inhibitor that
prefers unliganded channels and has profound effects on
the channel’s cGMP sensitivity. Our ﬁndings raise the
question of whether ATR might contribute to the slow
time course of dark adaptation by making it more difﬁ-
cult for channels to reopen despite the increase in cGMP
concentration after cessation of light.
 
MATERIALS AND METHODS
 
Expression of Channels in Xenopus Oocytes
 
CNG channel clones for the bovine rod 
 
 
 
 (CNGA1; accession no.
NM-174278) and rod 
 
 
 
 (CNGB1; EMBL/GenBank/DDBJ acces-
sion no. X89626) were provided by William N. Zagotta (Univer-
sity of Washington, Seattle, WA) (in the pGEMHE plasmid) and
Robert S. Molday (University of British Columbia, Vancouver,
Canada), respectively. The CNGB1 subunit was subcloned into
the pGEMHE plasmid in our lab. The pGEMHE plasmid con-
tained the untranslated sequence of the 
 
Xenopus
 
 
 
 
 
-globin gene to
promote high protein expression in oocytes (Liman et al., 1992).
Channel cRNA was made by in vitro transcription using Am-
bion’s mMessage mMachine
 
TM
 
 kit.
Partial ovariectomies were performed on anesthetized 
 
Xenopus
laevis
 
 frogs, and individual oocytes were isolated by treatment
with 1 mg/ml collagenase type 1A (Worthington) in a low-cal-
cium solution (82.5 mM NaCl, 2.5 mM KCl, 5 mM HEPES, 1 mM
MgCl
 
2
 
, at pH 7.6). Channel cRNA was injected into oocytes using
a Drummond “NANOJECT” injector. Typically, 
 
 
 
50 nl of 1 
 
 
 
g/
 
 
 
l cRNA was injected into each egg. For coexpression of 
 
 
 
 and 
 
 
 
subunits, cRNA for CNGA1 and CNGB1 were mixed in a ratio of
1:4 before injection. For current measurements from multichan-
nel patches, injected oocytes were incubated at 16
 
 
 
C for 1–12 d
before patch clamp experiments. For single-channel studies, the
same amount of cRNA was injected, but the oocytes were kept at
16
 
 
 
C overnight and then incubated at 4
 
 
 
C (to slow expression)
for 1–12 d before patch-clamp experiments. Oocytes were stored
in a solution containing: 96 mM NaCl, 2 mM KCl, 1.8 mM CaCl
 
2
 
,
5 mM HEPES, 1 mM MgCl
 
2
 
, 2.5 mM pyruvic acid, 100 U/ml pen-
icillin, and 100 
 
 
 
g/ml streptomycin, at pH 7.6. The vitelline
membrane was removed by mechanical dissection after treat-
ment with a hypertonic solution containing: 100 mM N-methyl-
D-glucamine, 2 mM KCl, 10 mM EGTA, 10 mM HEPES, and 1 mM
MgCl
 
2
 
, at pH 7.4.
 
Electrophysiological Solutions and their Application
 
The cell chamber for patch-clamp experiments was a glass Petri
dish. Water-soluble solutions were applied using a 36-solution
patch perfusion system, RSC-100 rapid solution changer (Molec-
ular Kinetics). Both sides of the patches were bathed in a low-
divalent sodium solution consisting of: 130 mM NaCl, 200 
 
 
 
M
EDTA, and 2 mM HEPES, at pH 7.2. The solution bathing the in-
tracellular surface of the patch contained various concentrations
of cGMP (Sigma-Aldrich) dissolved in the low-divalent solution.
Niﬂumic acid (500 
 
 
 
M; Sigma-Aldrich) was added to the extra-
cellular solution to block Ca
 
2
 
 
 
-activated Cl
 
 
 
 channels endoge-
nous to 
 
Xenopus
 
 oocytes.
ATR stocks were made in 100% ethanol and kept in amber
glass vials covered in aluminum foil and stored at 
 
 
 
80
 
 
 
C or
 
 
 
20
 
 
 
C until use. The purity and stability of the ATR stock was
checked by measuring the absorption spectrum (200–800 nm)
with a Beckman DU640 spectrophotometer. ATR was applied to
the intracellular or extracellular surface of patches by removing
50% of the bath volume, vigorously mixing the retinoid stock
into this solution using a glass Pasteur pipette in a glass beaker,
and then pouring this solution back into the remaining bath and
mixing again. We found that the greatest concentration of etha-
nol (0.1%) applied to any patch had no effect on cGMP-activated
current or on the seal resistance. Petri dishes and agar bridges
were replaced after each ATR experiment. ATR (Sigma-Aldrich)
stocks were applied to patches under dim room light conditions.
Spectroscopic measurements showed no degradation of ATR un-
der these conditions; however, degradation was apparent in
brighter room light.
 
Electrophysiological Recordings and Analysis
 
Standard patch clamp methods were used to record currents
from excised, inside-out, and outside-out oocyte patches. Pipette
openings were typically 0.5–5 
 
 
 
m in diameter with resistances of
1.0–15 M
 
 
 
 after ﬁre polishing. All recordings were obtained at
room temperature. Macroscopic currents were recorded at volt-
ages ranging from 
 
 
 
100 to 
 
 
 
100 mV in 50-mV steps from a hold-
ing potential of 0 mV. Leak currents were measured in the low di-
valent solution without cGMP for inside-out patches, and in 5
mM MgCl
 
2
 
 to block the CNG channels for outside-out patches.
These leak currents were subtracted from each record. All mac-
roscopic currents from multichannel patches were measured in
the steady-state after completion of voltage-dependent gating
(Karpen et al., 1988) and before signiﬁcant ion depletion effects
(Zimmerman et al., 1988). For heteromeric channels, the pres-
ence of the 
 
 
 
 (CNGB1) subunit was conﬁrmed by exposing the
patch to l-cis-diltiazem, which sensitively blocks heteromeric
channels but has little effect on homomeric channels (Chen et
al., 1993). Single-channel records were obtained as sequential 
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sweeps lasting 8 s each, while membrane voltage was held contin-
uously at 
 
 
 
80 mV. Pipettes were coated with dental wax before
polishing to reduce the noise from electrode capacitance.
ATR was added to patches only after allowing for completion
of the spontaneous increases in apparent cGMP afﬁnity of the
rod channel due to dephosphorylation by endogenous patch-
associated phosphatases (Gordon et al., 1992; Molokanova et al.,
1997). These increases in apparent cGMP afﬁnity took tens of
minutes and were monitored in inside-out patches by sampling
the current periodically at cGMP concentrations (typically 10
 
 
 
M) that were below the K
 
1/2
 
, while incubating the patch the rest
of the time in saturating cGMP (2 mM) to accelerate the process
(Molokanova et al., 1999). Since changing the cGMP concentra-
tion was not practical for outside-out patches, we simply incubated
these patches in 2 mM cGMP for 40–60 min before applying ATR.
For ATR dose–response curves on inside-out patches, the bath
contained either a saturating concentration of cGMP (2 mM) or a
low concentration of cGMP that activated 
 
 
 
7–8% of the maximal
current at 2 mM cGMP. The current was monitored for about an
hour after each addition of ATR to ensure that steady-state had
been reached. Typically, one or two ATR concentrations were
tested per patch. Experiments addressing the voltage dependence
of ATR inhibition were performed at a constant holding potential
of either 
 
 
 
50 or 
 
 
 
50 mV, with frequent sampling of the current at
that holding potential until steady-state had been reached. Then
the holding potential was jumped to the opposite voltage and again
monitored until steady-state was reached. For most patches, the
leak was rechecked at the end of the experiment by applying the
low divalent solution to the patch through a glass capillary tube an-
chored in the bath and attached to a syringe.
Patch currents were recorded using an Axopatch 1B or 200
patch-clamp ampliﬁer (Axon Instruments, Inc.) with analogue-
to-digital converters connected to a Macintosh Quadra or G4
computer running Pulse software (Instrutech). The data were
low-pass ﬁltered at 2 kHz and sampled at 10 or 25 kHz. Data anal-
ysis was performed using the IgorPro software package (WaveM-
etrics) or QuB Suite (www.qub.buffalo.edu).
The model depicted in Fig. 8 B and used to ﬁt the data in Figs.
3 and 8 A has the following deﬁnitions and equations:
O 
 
 
 
 open, ion-conducting channel.
C
 
1
 
 
 
 
 
 C
 
4
 
 
 
 
 
 closed, nonconducting channels.
R 
 
 
 
 ATR.
I 
 
 
 
 cyclic nucleotide–activated patch current.
I
 
max
 
 
 
 
 
 maximum possible current when all channels are open.
I
 
0
 
 
 
 
 
 maximum possible current at a ﬁxed cGMP or cAMP con-
centration with [R] 
 
 
 
 0.
I/I
 
max
 
 
 
 
 
 current normalized to I
 
max
 
.
I/I
 
0
 
 
 
 
 
 current normalized to I
 
0
 
.
K
 
cN
 
 
 
 
 
 association constant for cyclic nucleotide binding.
L 
 
 
 
 equilibrium constant for the allosteric opening transition
of the fully liganded channel.
K
 
1
 
 
 
 
 
 K
 
4
 
 
 
 
 
 association constants for ATR binding.
n 
 
 
 
 cooperativity constant for ATR binding.
I
Imax
----------
O []
O [] C1 [] C2 [] C3 [] C1R [] C2R [] C3R [] C4R [] ++++ + + +
------------------------------------------------------------------------------------------------------------------------------------------------------
L
L1 K 4LK 3 + () R []
n 1K 1 R []
n +
KcN
2 cGMP []
2 ----------------------------------
1K 2 R []
n +
1
2
---KcN cGMP []
----------------------------------- ++ + +
----------------------------------------------------------------------------------------------------------------------------------------------
=
=
 
Values of K
 
cN
 
 and L for activation of the channel by cGMP and
cAMP were derived from ﬁts of cyclic nucleotide dose–response
curves obtained in the absence of ATR (for cGMP: Fig. 3, circles;
and for cAMP, Fig. 2 of Crary et al., 2000). These values of K
 
cN
 
and L are comparable to those in the literature (e.g., Fodor et al.,
1997; Rosenbaum et al., 2003) and predict an open probability of
0.95 in 2 mM cGMP, which is similar to that measured in our sin-
gle-channel recordings (Dean et al., 2002). An open probability
of 0.05 in saturating cAMP is consistent with the ratio of maxi-
mum currents obtained for cAMP and cGMP after the spontane-
ous dephosphorylation process that shifts the cyclic nucleotide
dose–response curves of these channels in excised patches (see
 
materials and methods
 
; Gordon et al., 1992; Molokanova et
al., 1997).
 
RESULTS
 
Rod CNG channels were markedly inhibited by ATR,
especially at low cGMP concentrations. This is illus-
trated in Fig. 1, which presents current families from
two multi-channel patches in response to a series of
voltage pulses in the presence of saturating (left) or low
(right) cGMP, with or without ATR. Greater inhibition
was seen with only 30 nM ATR in low cGMP than with
ten times as much ATR in high cGMP. Fig. 2 shows aver-
age ATR dose–response curves for patches exposed to
low and saturating cGMP. For these data, “low” cGMP
was that required to give 
 
 
 
7.4% of the current ob-
tained for each patch with saturating cGMP. Because
there is some patch-to-patch (i.e., channel-to-channel)
variability in apparent cGMP afﬁnity, the exact concen-
tration of cGMP needed to obtain 7.4% I
 
max
 
 also varied,
but was 
 
 
 
10–15 
 
 
 
M. The ATR dose–response curves
were ﬁt with Hill relations with cooperativity constants
of 1.4–1.8, suggesting that more than one ATR mole-
cule may interact with each channel.
The native rod channel appears to be a heteromer
containing one 
 
 
 
 subunit (CNGB1) and three 
 
 
 
 sub-
units (CNGA1; Weitz et al., 2002; Zheng et al., 2002;
Zhong et al., 2002; for review see Zimmerman, 2002).
As shown in Fig. 2, ATR was approximately equally
effective at inhibiting heteromeric (CNGA1/CNGB1;
open triangles) and homomeric (CNGA1; ﬁlled cir-
I
I0
----
L1 1
KcN
2 cGMP []
2 ---------------------------------- 1
1
2
---KcN cGMP []
----------------------------------- ++ +




Imax
L1 K 4LK 3 + () R []
n 1K 1 R []
n +
KcN
2 cGMP []
2 ----------------------------------
1K 2 R []
n +
1
2
---KcN cGMP []
----------------------------------- ++ + +





Imax
---------------------------------------------------------------------------------------------------------------------------------------------------------------
=
I0
LI max ()
L1 1
KcN
2 cGMP []
2 ---------------------------------- 1
1
2
---KcN cGMP []
----------------------------------- ++ +
------------------------------------------------------------------------------------------------ =524 All-trans-retinal Inhibits Rod CNG Channels
cles) rod channels expressed in the oocytes. Thus,
in contrast to channel inhibition by pseudechetoxin
(Brown et al., 1999), calmodulin (Chen et al., 1994),
and l-cis-diltiazem (Chen et al., 1993), inhibition by
ATR appears not to be substantially affected by the
presence of the   subunit (CNGB1). This ﬁgure also
gives quantitative evidence for the high apparent afﬁn-
ity of CNGA1 for ATR at low cGMP concentrations
(open circles), as introduced in Fig. 1.
Fig. 3 shows that the effect of ATR inhibition was to
reduce both the apparent afﬁnity of the channel for
cGMP and the maximal current at saturating cGMP.
The saturating form of the lower curve suggests that
ATR is not a competitive inhibitor of cGMP binding,
since raising cGMP over a wide range does not relieve
ATR inhibition. The downward shift of the curve with
ATR suggests that ATR either inhibits opening of fully
liganded channels and/or partially blocks the open
channels, reducing the single-channel conductance.
Previous single-channel analysis (Dean et al., 2002) sug-
gests that a partial reduction in single-channel conduc-
tance is unlikely, and that ATR may induce long-lived
closed or inactivated states. Although a complete block
of the pore was not ruled out by those studies, open-
pore block is unlikely because ATR inhibits more effec-
tively at low than at high cGMP, i.e., at low, rather than
high, open probability. Furthermore, the data shown in
Fig. 3 are well-described by a model (solid curves)
which assumes that ATR interferes with the allosteric
opening transition of the channel and does not alter
its single-channel conductance (see materials and
methods and Fig. 8 for details of the model).
Inhibition of rod CNG channels (CNGA1) by ATR
was slow and often demonstrated two components. Fig.
4 A shows a typical time course of inhibition by 400 nM
ATR applied to the intracellular surface of an excised,
inside-out, multichannel patch. This time course was
described by two exponentials, with time constants of
119 and 1,667 s; for 11 patches showing two compo-
nents, the mean time constants ( SEM) were 110  
18.1 s and 2,081   666 s. Many patches demonstrated
Figure 1. ATR inhibits homomeric (CNGA1) rod channels
more potently at low than at saturating cGMP concentrations. Cur-
rents were measured from multichannel, inside-out patches of ho-
momeric (CNGA1) rod channels. The raw traces represent fami-
lies of cGMP-activated currents in response to voltage steps rang-
ing from  100 to  100 mV in 50-mV increments, from a holding
potential of 0 mV. Currents measured in the absence of cGMP
were subtracted from all traces. (Left) Current families depicting
control and inhibition at saturating cGMP (2 mM cGMP) by 300
nM ATR (50.6% inhibition). (Right) Current families showing
control and inhibition by 30 nM ATR (67.6% inhibition) at a
low cGMP concentration that elicits  7.4% of maximal cGMP in-
duced current.
Figure 2. The ATR dose–response relations for homomeric
(CNGA1) and heteromeric (CNGA1   CNGB1) rod CNG chan-
nels. Cyclic GMP–activated currents were measured at  100 mV
before and after ATR addition. Currents were monitored for  1 h
after ATR addition to ensure that the ATR inhibition had reached
steady-state. Averaged data, plotted with SEM (error bars) were ﬁt
with the Hill equation (solid or dashed curves): I/I0    IC50
n/
(IC50
n   [ATR]n), where I is current remaining at a given [ATR],
I0 is the current before ATR addition, IC50 is the concentration of
ATR required to achieve half maximal inhibition, and n is the Hill
(cooperativity) coefﬁcient. Filled circles, homomeric (CNGA1
only) rod channel dose–response relation for inhibition by ATR in
saturating (2 mM) cGMP. Data points are averaged from 19
patches; IC50   220 nM and n   1.4. Open triangles, heteromeric
(CNGA1 and CNGB1) rod channel dose–response relation for
ATR inhibition in saturating (2 mM) cGMP. Data points are from
ﬁve patches; IC50   185 nM and n   1.8. Open circles, homomeric
(CNGA1) rod channel dose–response relation for ATR inhibition
at cGMP concentrations evoking  7.4% activation. Data are from
ﬁve patches; IC50   20 nM and n   1.4.525 McCabe et al. 
only a single exponential time course with a time con-
stant of hundreds of seconds (854   105 s, 12 patches).
Because of the variability in the time course, we were
unable to ﬁnd any correlation between the relative
magnitude or time constant of each component and
the ATR concentration. We wondered whether access
of the lipophilic ATR to its interaction site(s) de-
pended on patch geometry, the lipid or protein compo-
sition of the membrane, or other variable patch prop-
erties (Karpen et al., 1988; Zimmerman et al., 1988;
Ruknudin et al., 1991). When the amount of inhibition
was changed by jumping voltage (see Fig. 7 below) or
cGMP concentration (see Fig. 6 below) after loading
the patch with ATR, changes in inhibition were more
rapid and were always described by a single exponen-
tial. This supports the notion that the slow, variable,
sometimes complex time course observed with ATR ad-
dition may reﬂect access problems relating to patch
structure.
If inhibition by ATR is slow because it involves re-
stricted access of ATR to a crevice or binding pocket of
the channel that is accessible primarily from the intra-
cellular surface, then inhibition might be slower or
weaker when ATR is applied to the outside surface of
the membrane. To test for this possibility, we measured
the time course of inhibition when ATR was applied to
outside-out patches. A typical time course for applica-
tion of 400 nM ATR to an outside-out patch is shown in
Fig. 4 B. These data demonstrate a single exponential
with a time constant of 6,748 s (112 min). Similar re-
sults were obtained with ﬁve other patches. The slower,
weaker action of ATR from the outside of the mem-
brane would be consistent with a mechanism in which
ATR exerts its effects via the intracellular surface of the
membrane or channel (see discussion). As reported
previously (Dean et al., 2002), reversal of ATR inhibi-
tion by washout from the chamber was difﬁcult, pre-
sumably because of the preference of this lipophilic in-
hibitor for the membrane or hydrophobic binding sites
over water. However, single-channel and multichannel
records provide evidence for reversibility of inhibition
by ATR. The one-channel patch shown in Fig. 5 shows
channel opening after a long shut period characteristic
of inhibition by ATR (Dean et al., 2002). This may re-
ﬂect dissociation of ATR from its interaction site(s),
and therefore reversibility, but we cannot rule out the
appearance of a new channel in the patch (however, si-
multaneous openings of two channels were never seen
in several minutes of recording from this patch).
Figure 3. cGMP dose–response relation for homomeric
(CNGA1) rod channels with and without 400 nM ATR. Steady-
state, cGMP-evoked currents were measured at  100 mV from sev-
eral patches with and without 400 nM ATR. Averaged data were
normalized to the maximum current obtained with 2 mM cGMP
and no ATR, and ﬁt with an allosteric model (smooth curves; see
materials and methods and Fig. 8 for details). Data points are
averaged from 2–7 patches, plotted with SEM (error bars). Circles:
cGMP dose–response relation without ATR. Model parameters:
L   19.8, KcN   7,200 M 1. Triangles: cGMP dose–response rela-
tion with 400 nM ATR. Model parameters: L   19.8, KcN   7,200
M 1, K1   9.0   1010 M n, K2   4.0   1010 M n, K3   2.8   1010
M n, K4   2.0   109 M n, R   400 nM, and n   1.43.
Figure 4. Time course of inhibition by 400 nM ATR in 2 mM
cGMP for inside-out and outside-out, multichannel patches con-
taining homomeric (CNGA1) rod channels. (A) Time course of
inhibition for this inside-out patch is best ﬁt with a double expo-
nential ( fast   119 s and  slow   1,667 s), although patches were of-
ten ﬁt with a single exponential. (B) The time course for outside-
out patches was so much slower than for inside-out patches that
very little inhibition was measured during the lifetime of the
patch; for this patch, a single-exponential ﬁt gave     6,748 s, al-
though clearly the current had not reached steady-state by the end
of the record.526 All-trans-retinal Inhibits Rod CNG Channels
Better evidence for reversibility of ATR inhibition
was provided by multichannel patches exposed to
jumps in either cGMP or voltage. At the start of the ex-
periment in Fig. 6, the addition of 100 nM ATR to a
patch in low cGMP gave  99% inhibition. This ATR
concentration normally inhibits much less at saturat-
ing cGMP (see Fig. 2). When the cGMP concentration
was raised to 5 mM in the continued presence of 100
nM ATR, there was an increase in current thought to
reﬂect two processes: (a) the opening of channels that
were initially associated with little or no cGMP and no
ATR; and (b) the opening of channels that were ini-
tially associated with ATR, but lost ATR upon binding
cGMP. The latter process is thought to account for
most of the current increase, since most of the chan-
nels are inhibited by ATR at low cGMP, as seen in the
data in Fig. 6 and supported by calculations of the
model from Fig. 8.
If ATR is a closed-state inhibitor, it should work bet-
ter at negative than at positive voltages, since the chan-
nel is slightly voltage dependent, with depolarization
favoring opening. Since ATR has no net charge, no ad-
ditional voltage dependence of inhibition is expected
unless the ATR interaction site moves in the electric
ﬁeld or is obscured by the movement of another region
of the channel. Fig. 7 illustrates a weak voltage depen-
dence consistent with that of channel gating. Thus, in
the left panel, applying ATR with a holding potential of
 50 mV reduced the current as channels became in-
hibited, but switching to  50 mV reduced the current
even more, as more channels closed and therefore be-
came more susceptible to ATR inhibition. Reversing
the order of the applied voltages (right panel) gave the
reverse response. This slight voltage dependence was
compared quantitatively with the voltage dependence
of gating in the absence of ATR and was found to be
similar. Thus, ATR did not induce any signiﬁcant volt-
age dependence beyond the existing weak voltage de-
pendence of channel gating. Interestingly, in both
cases, the time course of the voltage-induced jump in
current is much faster (    44 s for  50 mV and 64 s
for  50 mV) than that of the initial change in current
during application of ATR and may reﬂect the time re-
quired for preequilibrated ATR to interact with the
channel. The initial slow decreases in current shown in
Fig. 7 are consistent with that depicted in Fig. 4 A and
appear to reﬂect complex, patch-dependent parame-
ters, as discussed above.
The ﬁnding that ATR is a much more effective inhib-
itor at low than at high cGMP (Figs. 1 and 2) could re-
ﬂect a preference of ATR either for closed channels or
for channels without bound cyclic nucleotide (unli-
ganded channels). One way to distinguish between
these two possibilities is with the partial agonist, cAMP
(Gordon and Zagotta, 1995). For rod CNG channels, a
saturating concentration of cAMP (20 mM) gives only
 5% of the maximal activation obtained in saturating
cGMP (2 mM). Fig. 8 A compares ATR dose–response
relations for low cGMP, saturating cAMP and saturating
cGMP on homomeric rod CNG channels. The model
described in Fig. 8 B (equations in materials and
methods) approximates all three relations, and as-
Figure 5. Single-channel recordings in the pres-
ence of ATR suggest that the channel can reopen
after long-lived closed or inactivated states. Raw
current traces in A–C were recorded at a holding
potential of  80 mV from an inside-out patch
containing one homomeric (CNGA1) channel.
Data were ﬁltered at 2 kHz, and the sampling rate
was 25 kHz. The lower solid line represents the
zero-current level when the channel was closed.
The patch was bathed in saturating (2 mM)
cGMP (A), and then 200 nM ATR was added to
the bath (B and C). (A) A representative portion
of a control trace depicting normal channel activ-
ity in saturating cGMP; the channel spends the
majority of its time open. (B) After adding ATR,
the channel activity remained relatively normal
for a time. (C) Sometime before the start of this
sweep, the channel entered a long-lived closed
state, but reopening of the channel (with ATR
still in the bath) occurred near the end of the
sweep. Of the 3.2 s shown, the channel was in a
closed state for 2.5 s; another portion of the
record for this patch showed a 6-s closure. These
long-lived closed states with ATR have been docu-
mented previously (Dean et al., 2002).527 McCabe et al. 
sumes that ATR prefers closed over open channels, but
also unliganded over liganded channels (K1   K2  
K3    K4). We were not able to ﬁt the data by assuming
that all ATR equilibrium constants were equal, i.e., that
inhibition depended only on whether the channel was
closed, and not on the number of bound ligand mole-
cules. This is illustrated by the red dashed curve in Fig.
8 A, which is a prediction for the cAMP experiment if
ligand occupancy does not affect ATR inhibition (i.e.,
K1   K2   K3    K4). The model in Fig. 8 B further as-
sumes that when the fully liganded, open rod channel
binds ATR, it closes and cannot reopen with ATR
bound. The data could not be ﬁt with a model in which
the rod channel could open with ATR bound. Thus,
the data and model in Fig. 8 suggest that ATR prefers
unliganded, closed channels over channels that are
liganded and/or open.
Finally, the model depicted in Fig. 8 B also gave a
reasonable description of the cGMP dose–response
curves with and without ATR (Fig. 3). For these ﬁts, we
used the same constants as for the curves in Fig. 8 A,
changing only the concentrations of cGMP and ATR
to match the experimental conditions. Thus, the
reduction in current by ATR at saturating concen-
trations of cGMP can be explained simply by an in-
hibition of channel opening by ATR, and it is not nec-
essary to invoke a reduction in single-channel con-
ductance or competition between ATR binding and
cGMP binding.
DISCUSSION
Results presented here suggest that ATR is a potent,
reversible, closed-state inhibitor of both homomeric
(CNGA1) and heteromeric (CNGA1/CNGB1) rod CNG
channels. ATR acts best from the intracellular side of
the membrane to decrease the apparent agonist afﬁn-
ity, but it does not seem to compete with cyclic nucle-
otides at their binding domain. The inhibition is not
appreciably voltage dependent, and may involve multi-
ple ATR molecules per channel. Descriptions of the
data with an allosteric model suggest that ATR pre-
Figure 6. Current recovered with high cGMP after inhibition by
ATR in low cGMP. After applying 100 nM ATR to a bath solution
containing low cGMP (activating  7.5% of maximal current), the
patch current was monitored until the inhibition reached a steady-
state (99.5% inhibition). The cGMP concentration in the bath was
then raised to 5 mM, with the continued presence of 100 nM ATR
in the bath. The increase in [cGMP] opens some channels that
were previously unliganded, and also presumably relieves some of
the inhibition by ATR, since ATR is a less effective inhibitor in
high than in low cGMP (Figs. 1 and 2). After a gap representing
the time when cGMP was mixed into the chamber, the current re-
covery was ﬁt by a single-exponential rise with a time constant of
82 s.
Figure 7. Inhibition of homomeric (CNGA1) rod channels by
200 nM ATR in saturating (2 mM) cGMP showed no signiﬁcant
voltage dependence other than that expected with voltage-depen-
dent changes in open probability. For the top panel, an inside-out,
multichannel patch was maintained at a holding potential of  50
mV in 200 nM ATR and 2 mM cGMP and monitored to steady-
state. A double exponential provided the best ﬁt to the time
course of the inhibition, with  fast   206 s and  slow   3,779 s. After
steady-state was achieved, the holding potential was changed to
 50 mV. The time course of the resulting decrease in current (in-
crease in inhibition) was best ﬁt with a single exponential, with    
44 s. For the lower panel, the same experiment was performed on
another patch, except that the initial membrane potential was
 50 mV, and it was then switched to  50 mV. A double exponen-
tial provided the best ﬁt to the initial time course of inhibition,
with  fast   77 s and  slow   769 s. The time course of the increase
in current (decrease in inhibition) after switching the voltage to
 50 mV was best ﬁt with a single exponential, with     64 s. These
changes in ATR inhibition with voltage are consistent with the ex-
pected voltage-dependent changes in open probability and the
greater ATR inhibition of closed versus open channels.528 All-trans-retinal Inhibits Rod CNG Channels
fers unliganded channels, but is also very effective on
closed, liganded channels. The model assumes that
ATR interacts more weakly with open channels and
drives them to close as well.
It is not clear whether ATR has its effects by interact-
ing directly with the channel protein or some interme-
diary protein, or by altering bilayer–channel interac-
tions. If ATR alters bilayer–protein interactions, it may
disrupt lipid rafts in the membrane and thereby alter
the behavior of channels embedded in the rafts (Edi-
din, 1997; Brown and London, 1998; Jacobson and
Dietrich, 1999; Martens et al., 2000; Brady et al., 2004),
it may form retinoid-rich microdomains (Boeck and
Zidovetzki, 1988) that affect channel function, or it
may alter physical properties of the bilayer, such as
curvature, at the lipid–protein interface (Lundbaek
et al., 1996; Cantor, 1999; Lundbaek and Andersen,
1999). Changes in bilayer curvature, for example,
have been shown to have dramatic effects on the
dimerization of gramicidin channels (Lundbaek and
Andersen, 1994). Evidence for lipid rafts has been
found in rod outer segment membranes (Seno et al.,
2001) and in oocytes (Luria et al., 2002), and a recent
report (Brady et al., 2004) shows that disruption of
lipid rafts drastically reduces the apparent cAMP afﬁn-
ity of olfactory CNG (CNGA2) channels. Finally, it
should be mentioned that Schiff base reactions can
occur between ATR and lipids; this offers another po-
tential action of ATR via the bilayer. However, this
mechanism seems unlikely here in light of our previ-
ous ﬁnding (Dean et al., 2002) that the rod CNG
channel is inhibited quite well by all-trans-retinol,
which cannot form a Schiff base.
On the other hand, retinoids, including ATR, are
known to interact directly with proteins, such as rho-
dopsin, retinoid binding proteins, and transcrip-
tion factors (Newcomer et al., 1998; Nau and Blaner,
1999; Noy, 2000; Kefalov et al., 2001). These interac-
tions may involve covalent bonds. A putative ATR bind-
ing pocket within the channel protein might include
residues at locations that are distant from each other in
the primary sequence, but near each other in the three-
dimensional structure of the channel; for example, in
rhodopsin, the binding pocket is made up of residues
that are contributed by adjacent transmembrane   heli-
ces. Direct interactions with the channel could involve
hydrophobic crevices or domains, either among the
transmembrane segments or within hydrophobic areas
in the cytoplasmic amino- and carboxy-terminal do-
mains. It is also possible that ATR acts by way of an-
other protein associated with the channel, rather than
directly on the channel; however, we have found similar
inhibition of the channel in the native rod outer seg-
ment membrane (unpublished data), where protein
(and lipid) components are different.
Our results suggest that ATR is a closed-state inhibi-
tor, as are some other lipophilic agents, including tetra-
caine (Fodor et al., 1997) and dequalinium (Rosen-
baum et al., 2004). However, unlike these inhibitors,
ATR appears to discriminate not only between closed
and open channels, but also between liganded and un-
liganded channels. This raises the question of whether
ATR may interact at sites within or near the cyclic nu-
cleotide binding domain. Although ATR does not ap-
pear to be a competitive inhibitor of cyclic nucleotide
binding, it may interact with a region whose conforma-
tion changes in response to cyclic nucleotide binding
(Matulef and Zagotta, 1999).
Figure 8. ATR appears to prefer closed, unliganded channels,
and to interfere with channel opening. ATR dose–response rela-
tions for homomeric (CNGA1) channels activated by cGMP or
cAMP. (A) Data were measured as described in Fig. 2 for ATR
dose–response curves in saturating (2 mM) cGMP (blue ﬁlled cir-
cles), saturating (20 mM) cAMP (red squares; giving only 5% of
the activation obtained with 2 mM cGMP), and low ( 10–15  M)
cGMP (green open circles; giving  7.4% of the activation ob-
tained with 2 mM cGMP). Error bars are SEM values. Averaged
data points from 2–7 patches were normalized to Io and ﬁt with the
model (B) described above (see materials and methods and re-
sults), where K1   9.0   1010 M n, K2   4.0   1010 M n, K3  
2.8   1010 M n, K4   2.0   109 M n, and n   1.43. For saturating
and low cGMP, L   19.8 and KcN   7,200 M 1; for cAMP, L  
0.055 and KcN   1,144 M 1. The red dashed line represents the
prediction of the model for cAMP if ATR binding depends only on
the open probability and not on ligand occupancy (i.e., K1   K2  
K3   9   1010 M n).529 McCabe et al. 
A comparison of channel inhibition by extracellu-
larly and intracellularly applied ATR may give clues as
to the mechanism of its action. Retinoids insert into bi-
layers, and ﬂip-ﬂop across them, very rapidly—on a
millisecond time scale. However, they take at least sec-
onds to leave a bilayer into an aqueous solution, and
retinoid interactions with proteins take seconds to
minutes (Noy, 1999). We found that channel inhibi-
tion was orders of magnitude slower and less effective
when ATR was applied to the extracellular surface of
the membrane than when it was applied to the intra-
cellular surface. One possible explanation for this re-
sult is that the ATR interaction site(s) was accessible
only from the intracellular surface of the channel.
Thus, when ATR was applied extracellularly, the chan-
nel only sensed the small fraction of the applied ATR
that had passed through the bilayer and remained
near the intracellular surface long enough to ﬁnd the
interaction site(s).
The physiological relevance of ATR inhibition of rod
CNG channels remains to be determined. A bright
light sufﬁcient to bleach all rhodopsin molecules in a
rod is expected to produce 3 mM ATR in the rod outer
segment (Saari, 1999). Although most of this ATR is ex-
pected to associate with the disk membranes, some will
most likely be in or near the plasma membrane and
therefore near the CNG channels. To date, the only ret-
inoid binding protein that has been described in rods
is IRBP, which is produced by the rods and secreted
into the extracellular matrix. It is possible that IRBP
may buffer intracellular, as well as extracellular, ATR.
Furthermore, retinol dehydrogenase, which converts
ATR to all-trans-retinol after light absorption, would
also reduce the amount of ATR available to inhibit the
CNG channels. However, the IC50 for ATR inhibition of
the channel is 25 nM with  10–15   M cGMP, and
should be much lower when the free cGMP concentra-
tion is in the range expected in vivo:  6  M in the dark
and even lower in the light (Nakatani and Yau, 1988).
Thus, it is reasonable to assume that some inhibition is
possible in a rod exposed to bright, prolonged light.
One potential caveat to this proposal is the fact that rod
CNG channels are modulated by phosphorylation
enzymes, Ca2 -binding proteins, and perhaps other
agents; thus, their sensitivity to ATR in vivo may not be
the same as that in our excised patches. If ATR does in-
deed inhibit the channels in the intact rod, what role
might this inhibition play in visual transduction? One
possibility is that it could contribute to the slow time
course of dark adaptation after an exposure to bright
and/or prolonged light, since the reduced apparent
cGMP afﬁnity of the channels would tend to make
them remain closed even when the cGMP levels are re-
covering. Finally, inhibition of the channels by ATR
may occur in certain disease conditions, such as in Star-
gardt’s disease, in which there is an abnormal accumu-
lation of ATR.
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